Sciele Pharma Announces Availability Of Ulesfia (Benzyl Alcohol Lotion 5%), First Prescription Non-Neurotoxic Head Lice Treatment
Sciele Pharma, Inc., a Shionogi Company, announced the availability of Ulesfia (Benzyl Alcohol Lotion 5%), the first and only prescription medication that kills head lice by asphyxiation without potential neurotoxic side effects. Approved by the U.S. Food & Drug Administration (FDA), Ulesfia is indicated for the topical treatment of head lice infestation in patients 6 months of age and older. Ulesfia is available now by prescription nationwide in time for peak head lice season.
Mental Health
Center For Vision Restoration Of UPMC And Pitt Receives Multi-Million Dollar Gift To Be Matched By UPMC
The Center for Vision Restoration of UPMC and the University of Pittsburgh today announced a $3 million gift from Louis J. Fox, a Pennsylvania native and Pitt graduate. UPMC has pledged to match Mr. Fox"s donation to the Center. Mr. Fox, a retired commodity merchant banker and trader, has embraced the Center"s mission to discover cures for blindness and vision impairment through a joint program of the UPMC Eye Center and McGowan Institute for Regenerative Medicine. "His generous gift will aid us in our efforts to pioneer comprehensive, patient-driven research and clinical therapies to treat people who through disease, accident or injury have limited sight. To honor his generosity, the Center will now be known as the Louis J. Fox Center for Vision Restoration," said Center executive director Maj. Gen. (retired) Gale Pollock, who, as former Deputy Surgeon General of the U.S. Army, recognized the need to find ways to restore lost vision. More than one in 10 of all combat wounds during the conflicts in Iraq and Afghanistan have been eye injuries and, in some cases, have left service members with impaired vision, Gen. Pollock noted. Unfortunately, there often is very little that can be done to restore sight after severe eye trauma. In addition, the World Health Organization estimates that about 120 million people worldwide are visually impaired due to cataracts, corneal scarring, glaucoma, macular degeneration, diabetic retinopathy and other conditions. Those figures hit home for Mr. Fox, who was diagnosed 10 years ago with central retinal vein occlusion (CRVO), an incurable condition caused by blood vessel obstruction. It rapidly left him with life-changing vision loss, first in his right eye and then in his left three years later. More than 100,000 Americans are estimated to have CRVO. "Before my situation, I knew very little about vision loss," said Mr. Fox, who is married with two grown children and currently resides in Ft. Lauderdale, Fla. and Taconic, Conn. "As an avid pilot and sailor, I had taken my good vision for granted. Losing it has been extremely difficult. I learned of the Center for Vision Restoration at UPMC soon after it was established in September 2008, and of the promising work being done here." "My heartfelt desire is that my contribution speeds the discovery and development of therapies that will make it possible for people to see again," he added. The University of Pittsburghflorist commented:
this information is totally fresh and other best thing is that the entire information is based on reality. Nice peace of work. I appreciate
14.05.2012